Caspase activation is required for nitric oxide-mediated, CD95(APO- 1/Fas) - Dependent and independent apoptosis in human neoplastic lymphoid cells

Blood

Volumn 91, Issue 11, 1998, Pages 4311-4320

  Chlichlia, Katerina ^a   Peter, Marcus E ^a   Rocha, Marian ^a   Scaffidi, Carsten ^a   Bucur, Mariana ^a   Krammer, Peter H ^a   Schirrmacher, Volker ^a   Umansky, Victor ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; N(G) METHYLARGININE; NITRIC OXIDE; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATTLE; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032100446     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4311     Document Type: Article

References (52)

1. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89:6711, 1992
2. Nathan CF, Xie Q-W: Nitric oxide synthases: Rolles, tolls, and controls. Cell 78:915, 1994
3. Moncada S, Palmer RJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109, 1991
4. Nathan CF, Hibbs JB: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65, 1991
5. Stuehr DJ, Nathan CF: Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543, 1989
6. Li L, Nicolson GL, Fidler IJ: Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 51:245, 1991
7. Li L, Kilbourn RG, Adams J, Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51:2531, 1991
8. Xie K, Huang S, Dong Z, Gutman M, Fidler J: Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55:3123, 1995
9. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080, 1993
10. Fehsel K, Kršncke K-D, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V: Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155:2858, 1995
11. Cui S, Reichner JS, Albina JE: Nitric oxide (NO) induces apoptosis in ConA-stimulated splenocytes. FASEB J 8:4470, 1994
12. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 55:36, 1996
13. Xie K, Huang S, Dong Z, Fidler J: Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 3:1043, 1993
14. Umansky V, Bucur M, Schirrmacher V, Rocha M: Activated endothelial cells induce apoptosis in lymphoma cells: Role of nitric oxide. Int J Oncol 10:465, 1997
15. Geng Y-J, Hellstrand K, Wennmalm A, Hansson GK: Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α . Cancer Res 56:866, 1996
16. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181:1333, 1995
17. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
18. Baker SJ, Reddy EP: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1, 1996
19. Nagata S: Apoptosis by death factor. Cell 88:355 1997
20. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM: FADD/MORT1 is a common mediator of CD95(Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961, 1996
21. Chinnaiyan AM. O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995
22. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain. J Biol Chem 270:7795, 1995
23. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
24. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803, 1996
25. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794, . 1997
26. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboudi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
27. Dhein J, Walczak H, BŠumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 373: 438, 1995
28. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
29. Friesen C, Herr I, Kramrner PH, Debatin K-M: Involvement of the CD95(APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 2:574, 1996
30. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673, 1995
31. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687, 1996
32. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A: Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 6:750, 1996
33. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM: The receptor for the cytotoxic ligand TRAIL. Science 276:111, 1997
34. Pan G, Ni J, Wie YF, Yu G, Gentz R, Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815, 1997
35. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatcn M., Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818, 1997
36. Peter ME, Dhein J, Ehret A, Hellbardt S, Walczak H, Moldenhauer G, Krammer PH: APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int Immunol 7:1873, 1995
37. Nawroth P, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740, 1986
38. Trauth BC, Klas C, Peters AM, Matzku S, Mšller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
39. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139:271, 1991
40. Chlichlia K, Busslinger M, Peter ME, Walczak H, Krammer PH, Schirrmacher V, Khazaie K: ICE-proteases mediate HTLV-1 Tax-induced apoptotic T-cell death. Oncogene 14:2265, 1997
41. Vennström B, Bishop JM: Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell 28:135, 1982
42. Scaffidi C, Medema JP, Krammer PH, Peter ME: FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272:26953, 1997
43. Mariani SM, Matiba B, Armandola EA, Krammer PH: Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 137:221, 1997
44. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270:3255, 1995
45. Jeremias I, Herr I, Boehler T, Debatin K-M: TRAIL/APO-2-Ligand induced apoptosis in human T-cells. Eur J Immunol 28:143, 1998
46. Kwon NS, Stuehr DJ, Nathan CF: Inhibition of tumor cell ribonucleotide ribonuclease by macrophage-derived nitric oxide. J Exp Med 174:761, 1991
47. Kurose I, Miura S, Fukumura D, Yonei Y, Saito H, Tada S, Suematsu M, Tsuchiya M: Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells. A comparison with oxidative burst. Cancer Res 53:2676, 1993
48. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808, 1996
49. Melkova Z, Lee SB, Rodriguez D, Esteban M: Bcl-2 prevents nitric oxide-mediated apoptosis and poly(ADP-ribose) polymerase cleavage. FEBS Lett 403:273, 1997
50. Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 18:44, 1997
51. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675, 1998
52. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin K-M: Betulinic acid triggers CD95(APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57:4956, 1997